Rite Aid Announces Availability of OTC NARCAN Nasal Spray at All Locations

Rite Aid (NYSE: RAD) announced today that NARCAN Nasal Spray, a medication used to reverse the effects of an opioid overdose, is available at all locations nationwide, including Bartell Drugs in the Pacific Northwest. NARCAN Nasal Spray can be purchased over the counter without a prescription.

NARCAN Nasal Spray (naloxone HCl 4 mg) is a medication designed to rapidly reverse the effects of a life-threatening opioid emergency and is the standard treatment for opioid overdose. It is now FDA-approved for OTC use and is available for purchase at Rite Aid stores nationwide and online at RiteAid.com.

“By making NARCAN Nasal Spray easily accessible over the counter to Rite Aid customers, more people will have the ability to save a life,” said Summer Kerley, Vice President, Clinical Services and Market Access Solutions for Rite Aid. “We encourage customers to ask their local Rite Aid pharmacist how they can be prepared to reverse an opioid emergency.”

Each carton of NARCAN Nasal Spray contains two single-dose devices. Each device contains one dose of medicine. The carton is readily available on shelves and at the pharmacy counter at Rite Aid stores and is priced at $45.99.

About Rite Aid Corporation

Rite Aid is a full-service pharmacy that improves health outcomes. Rite Aid is defining the modern pharmacy by meeting customer needs with a wide range of vehicles that offer convenience, including retail and delivery pharmacy, as well as services offered through our wholly owned subsidiaries, Elixir, Bartell Drugs and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, consists of accredited mail and specialty pharmacies, prescription discount programs and an industry leading adjudication platform to offer superior member experience and cost savings. Health Dialog provides healthcare coaching and disease management services via live online and phone health services. Regional chain Bartell Drugs has supported the health and wellness needs in the Seattle area for more than 130 years. Rite Aid employs more than 6,300 pharmacists and operates more than 2,300 retail pharmacy locations across 17 states. For more information, visit www.riteaid.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230911566863/en/

The Rite Aid Stock at the time of publication of the news with a fall of -0,81 % to 0,610USD on Tradegate stock exchange (11. September 2023, 10:39 Uhr).